Fibromatosis: Benign by Name but not Necessarily by Nature

Clinical Oncology

Volumn 19, Issue 5, 2007, Pages 319-326

  Tolan, S ^a   Shanks, J H ^a   Loh, M Y ^a   Taylor, B ^a   Wylie, J P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Desmoid tumour; fibromatosis; radiotherapy; surgery; systemic therapy

Indexed keywords

ALPHA INTERFERON; APC PROTEIN; BETA CATENIN; BETA INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; ETOPOSIDE; IFOSFAMIDE; IMATINIB; METHOTREXATE; MITOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STEM CELL FACTOR RECEPTOR; SULINDAC; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

ABDOMINAL FIBROMATOSIS; ADENOMATOUS POLYP; ARTICLE; BENIGN TUMOR; BLOOD TOXICITY; CLINICAL TRIAL; DESMOID TUMOR; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; FIBROMATOSIS; FIBROSARCOMA; GARDNER SYNDROME; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; SOFT TISSUE SARCOMA; TUMOR RECURRENCE; TUMOR REGRESSION;

DIAGNOSIS, DIFFERENTIAL; DOSE FRACTIONATION; FIBROMATOSIS, AGGRESSIVE; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 34248594924     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.03.002     Document Type: Article

References (53)

1. In: Weiss S.W., and Goldblum J.R. (Eds). Enzinger and Weiss's soft tissue tumors (2001), Mosby, St Louis
2. Mehrota A.K., Sheikh S., Aaron A.D., Montgomery E., and Goldblum J.R. Fibromatoses of the extremities: clinicopathological study of 36 cases. J Surg Oncol 74 (2000) 291-296
3. Li M., Cordon-Calo C., Gerald W.L., and Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol 27 (1996) 939-943
4. Lucas D.R., Shroyer K.R., McCarthy P.J., Markham N.E., Fujita M., and Enomoto T.E. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol 21 (1997) 306-311
5. Fletcher J.A., Naeem R., Xiao S., and Corson J.M. Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 79 (1995) 139-143
6. Kuluyat M.N., Karakousis C.P., Keaney C.M., McCorvey D., Bem J., and Ambrus Sr J.L. Desmoid tumor: a pleomorphic lesion. Eur J Surg Oncol 25 (1999) 487-497
7. Burke A.P., Sobin L.H., Shekitka K.M., Federspiel B.H., and Helwig E.B. Intraabdominal fibromatosis: a pathological analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 12 (1990) 335-341
8. Tejpar S., Nollet F., Li C., et al. Predominance of beta-catenein mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 11 (1999) 6615-6620
9. Magro G., Gurrera A., and Bisceglia M. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma. Histopathology 42 (2003) 233-238
10. Deyrup A.T., Tretiakova M., and Montag A.G. Estrogen receptor-beta expression in extra-abdominal fibromatosis: an analysis of 40 cases. Cancer 106 (2006) 208-213
11. Leithner A., Gapp M., Radl R., et al. Immunohistochemical analysis of desmoid tumours. J Clin Pathol 58 (2005) 1152-1156
12. Montgomery E., Torbenson M.S., Kaushal M., Fisher C., and Abraham S.C. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 26 (2002) 1296-1301
13. Yantiss R.K., Spiro I.J., Compton C.C., and Rosenberg A.E. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of small bowel. A clinically important differential diagnosis. Am J Surg Pathol 24 (2000) 947-957
14. Mace J., Bierman J.S., Sondak V., et al. Response of extraabdominal tumors to therapy with imatinib mesylate. Cancer 95 (2002) 2373-2379
15. Lucas D.R., al-Abbadi M., Tabaczka P., Hamre M.R., Weaver D.W., and Mott M.J. C-kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol 119 (2003) 339-345
16. Miettinen M. Are desmoid tumors c-kit positive?. Am J Surg Pathol 25 (2001) 549-550
17. Saito T., Oda Y., Tanaka K., et al. β-catenin nuclear expression correlates with cyclin D1 over expression in sporadic desmoid tumors. J Pathol 195 (2001) 222-228
18. Healey J.C., Reznek R.H., Clark S.K., Phillips R.K., and Armstrong P. MR appearances of desmoid tumours in familial adenomatous polyposis. Am J Roentgenol 169 (1997) 465-472
19. Casillas J., Sais G.J., Greve J.L., Iparraguirre M.C., and Morillo G. Imaging intra- and extraabdominal desmoid tumors. Radiographics 11 (1991) 959-968
20. Robbin M.R., Murphey M.D., Temple H.T., Kransdorf M.J., and Choi J.J. Imaging of musculoskeletal fibromatosis. Radiographics 21 (2001) 586-600
21. Francis I.R., Dorovini-Zis K., Glazer G.M., Lloyd R.V., Amendola M.A., and Martel W. The fibromatoses: CT-pathological correlation. Am J Roentgenol 147 (1986) 1063-1066
22. Kransdorf M.J., and Murphey M.D. Radiological evaluation of soft tissue masses: a current perspective. Am J Roentgenol 175 (2000) 575-587
23. Tanaka H., Harasawa A., and Furui S. Usefulness of MR imaging in assessment of tumor extent of aggressive fibromatosis. Radiat Med 23 (2005) 111-115
24. Hartman T.E., Berquist T.H., and Fetsch J.F. MR imaging of extraabdominal desmoids: differentiation from other neoplasms. Am J Roentgenol 158 (1992) 581-585
25. Quinn S.F., Erickson S.J., Dee P.M., et al. MR imaging in fibromatosis: results in 26 patients with pathological correlation. Am J Roentgenol 156 (1991) 539-542
26. Miralbell R., Suit H.D., Mankin H.J., Zuckerberg L.R., Stracher M.A., and Rosenberg A.E. Fibromatoses: from post surgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys 18 (1990) 535-540
27. Goy B.W., Lee S.P., Eiber F., et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumour. Int J Radiat Oncol Biol Phys 39 (1997) 659-665
28. Acker J.C., Bossen E.H., and Halpen E.C. The management of desmoid tumours. Int J Radiat Oncol Biol Phys 26 (1993) 851-858
29. Spear M.A., Jennings L.C., Mankin H.J., et al. Individualizing management or aggressive fibromatosis. Int J Radiat Oncol Biol Phys 40 (1998) 637-645
30. Ballo M.T., Zagars G.K., Pollack A., Pisters P.W.T., and Pollock R.A. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17 (1999) 158-167
31. Gronchi A., Casali P.G., Mariani L., et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis; a series of patients treated surgically at a single institution. J Clin Oncol 21 (2003) 1390-1397
32. McFarlane J. Clinical reports on the surgical practice of Glasgow Royal Infirmary. Glasgow: D Robertson (1832)
33. Micke O., Seegenschmiedt M.H., and The German cooperative Group on Radiotherapy for Benign Diseases. Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national patterns of care study. Int J Radiat Oncol Biol Phys 61 (2005) 882-891
34. Posner M.C., Shiu M.H., Newsome J.L., Hajdu S.I., Gaynor J.J., and Brennan M.F. The desmoids tumor: not a benign disease. Arch Surg 124 (1989) 191-196
35. Lofti A.M., Dozios R.R., Gordon H., et al. Mesenteric fibromatosis complicating familial adenomatous polyposis; predisposing factors and results of treatment. Int J Colorectal Dis 4 (1989) 30-36
36. Berk T., Cohen Z., McLeod R.S., et al. Management of mesenteric desmoid tumors in familial adenomatous polyposis. Can J Surg 35 (1992) 393-395
37. Catton C.N., O'Sullivan B., Bell R., Cummings B., Fornasier V., and Panzarella T. Aggressive fibromatosis: optimisation of local management with a retrospective failure analysis. Radiother Oncol 34 (1995) 17-22
38. Merchant N.B., Lewis J.J., Woodruff J.M., Leung D.H.Y., and Brennan M.F. Extremity and trunk desmoid tumors. Cancer 86 (1999) 2045-2052
39. Zlotecki R.A., Scarborough M.T., Morris C.G., et al. External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 54 (2002) 177-181
40. Jelinek J.A., Stelzer K.J., Conrad E., et al. The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 50 (2001) 121-125
41. Chew C., Reid R., and O'Dwyer P.J. Evaluation of the long term outcome of patients with extremity desmoids. Eur J Surg Oncol 30 (2004) 428-432
42. Nuyttens J.J., Rust P.F., Thomas C.R., and Turrisi A.T. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. A comparative review of 22 articles. Cancer 88 (2000) 1517-1523
43. Ewing J. Neoplastic disease (1928), WB Saunders, Philadelphia
44. Leibel S.A., Wara W.M., Hill D.R., et al. Desmoid tumors: local controls and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys 9 (1983) 1167-1171
45. Sherman N.E., Romsdahl M., Evans H., Zagars G., and Oswald M.J. Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys 19 (1990) 37-40
46. Suit H.D. Radiation dose and response of desmoid tumors. Int J Radiat Oncol Biol Phys 19 (1990) 225-227
47. Hansmann A., Adolph C., Vogel T., Unger A., and Moeslein G. High dose tamoxifen and sulindac as first line treatment for desmoid tumors. Cancer 100 (2004) 612-620
48. Mukhergee A., Malcolm A., de la Hunt M., and Neal D.E. Pelvic fibromatosis (desmoid) - treatment with steroids and tamoxifen. Br J Urol 75 (1995) 559-560
49. Hial V., Horakova Z., Shaff F.E., and Ma B. Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. Eur J Pharmacol 37 (1976) 367-376
50. Weiss A.L., and Lackman R.D. Low dose chemotherapy of desmoid tumors. Cancer 64 (1989) 1992-1994
51. Azarelli A., Gronchi A., Bertulli R., et al. Low dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 92 (2001) 1259-1264
52. Okuno S.H., and Edmonson J.H. Combination chemotherapy for desmoid tumors. Cancer 97 (2003) 1134-1135
53. Samuels B.L. Management of recurrent desmoid tumor after surgery and radiation: role of cytotoxics and non-cytotoxic therapies. Surg Oncol 8 (1999) 191-196